from self-harm [8, 10] . Most completed suicides occur within 2-3 years of surgery (70%) [8, 9] . In 2010, completed suicide rates in Pennsylvania weight loss surgery patients were 13.7 per 10,000 among men and 5.2 per 10,000 among women, compared to 2.4 per 10,000 among men and 0.7 per 10,000 women in the general population [6] . A recent systemic review [5] evaluating completed suicide after weight loss surgery also found elevated suicide rates (4.1 per 10,000). Hypothesized determinants of intentional, fatal self-harm after weight loss surgery include inadequate weight loss or gains in quality of life, weight regain or comorbidity reoccurrence, psychosocial concerns, unrealistic expectations, mobility issues, or poor self-esteem [2, 5, 7] , but few data have thoroughly evaluated these hypotheses.
Fatal overdose, whether intentional or accidental, has been observed in some weight loss surgery patients. Adams et al. [11] found overdose as the cause of death in 15 of 90 weight loss surgery patients who died from non-disease causes (16.7%). Bhatti and colleagues [12] found overdose to be the most common method of self-harm in weight loss surgery patients, accounting for approximately 73% of self-harmrelated emergency room visits. In the Swedish Obesity Study (SOS), substance abuse was documented in 51% of gastric bypass patients that experienced non-fatal self-harm episodes [7] . Reductions in the amount of medications and substances required after weight loss to achieve desired therapeutic levels or effects, changes in the way substances and medications are absorbed [5, 13] , and psychosocial changes may contribute to the risk of overdose postoperatively. The prevalence of alcohol use disorders is higher postoperatively compared to preoperatively [14] , which may also contribute to overdose risk.
Clinical factors associated with overdose or intentionally caused deaths are poorly understood. Estimates of previous histories of self-harm or suicidality in weight loss surgery populations range from 3 to 11% [7, [15] [16] [17] [18] , and may be indicative of future self-harm behaviors. Davidson and colleagues [9] found younger gastric bypass patients (< 35 years), particularly younger females, to be more likely to die from external causes. Morgan and Kwok [3] found younger age, previous psychiatric hospitalizations for depression, gastrointestinal complications, and a lack of private insurance to be associated with self-harm behaviors postoperatively. Greater weight-related stigma [17] is associated with suicidal ideation or behavior in bariatric surgery candidates, though this relationship has not been evaluated postoperatively. More investigations of clinical factors associated with fatal self-harm or overdose-related events after surgery are needed to improve informed consent to surgery and patient care.
In a previous study, Lent et al. [8] found an elevated risk of externally caused death in younger bariatric surgery patients compared to non-surgical controls matched on age, weight, sex, and diabetes status. The present study expanded this work by evaluating additional clinical factors of weight loss surgery patients who died from intentional self-harm or accidental overdose from a cohort of 3236 weight loss surgery patients. Specifically, the objective of this study was to define the clinical and psychosocial histories of Roux-en-Y gastric bypass (RYGB) patients who died from intentional self-harm or accidental overdose using data from their health records. This exploratory, descriptive study assessed (1) known factors related to self-harm or overdose in RYGB patients (i.e., age, sex, history of self-harm or depression); and (2) novel or underexplored factors that may relate to risk of death by self-harm or overdose for future study (i.e., psychosocial factors, weight loss achieved versus expectations, medication use).
Materials and Methods
Twenty-two patients completed RYGB at a large, rural comprehensive medical center between January 2004 and December 2014 (n = 3236 possible RYGB patients) and died from intentional self-harm or accidental overdose through December 2015.
Data for the 22 RYGB patients were derived from three sources: (1) specific cause of death was obtained through an application to the National Death Index (NDI) and details of this procedure were previously reported [8] ; (2) participant characteristics (age, sex, surgery type, etc.) at the time of surgery, medications (preoperative psychotropic and opioid; postoperative opioid), and diagnoses (problem list or ICD codes for diabetes, hypertension, dyslipidemia, and psychiatric disorders) were collected from the electronic health record (EHR); and (3) de-identified preoperative behavioral health evaluations.
The preoperative program for weight loss surgery involves a 6-12-month multidisciplinary curriculum (medical evaluations, dietary and nutritional counseling, and psychosocial evaluation) with the goal of 10% body weight loss [19] . The psychosocial evaluation inquires about weight and dieting history, psychiatric history (including current and previous psychotherapy and medications), pain and related medication use, self-harm and substance use histories, motivation for surgery, readiness and understanding of the risks and postoperative diet and lifestyle, among other factors. Patients are provided a Blight status^indicating clearance status for surgery from the program's Behavioral Medicine team (i.e., Bgreen light,^cleared; Byellow light,^delayed clearance and behavioral goals; Bred light,^inappropriate candidate). Reasons for delayed clearance (Byellow light^) typically include difficulty making dietary and other behavioral changes, poor understanding, or eating or mental health concerns. A psychological assessment for depression is also administered [20, 21] . Postoperatively, patients are scheduled for follow-up visits at the bariatric surgery clinic 1 and 2 weeks, and 2, 5, 8, and 12 months following surgery, and yearly thereafter.
A data analyst de-identified the medical records to eliminate all potential protected health information present in medical note free text, including physician names, places of work, and family names. Specific variables explored included: Select EHR data were also reported for patients that died from internal causes and for the overall RYGB cohort. This study was approved by the health system's Institutional Review Board.
Analyses
Descriptive statistics were used to describe the data. The primary investigator created a list of clinical factors to report in patients' psychosocial evaluations. Two doctoral-level students independently reviewed and coded the de-identified EHR data according to the list of factors (i.e., general mental health, self-harm and addiction histories, marital status and education levels, smoking and alcohol use, life stressors, and social support). Raters were blinded to the patients' cause of death.
Results
Inter-Rater Reliability Raters' coding of the preoperative psychosocial evaluation text was compared for key clinical factors of interest. For most categories, ratings were in agreement at a rate of 85% or higher. For self-harm history, raters were only in 66% accordance and therefore a third party was invited to review the discrepant text and make a final decision.
Demographics, Clinical Characteristics, and Cause of Death Of the 146 total post-RYGB deaths, 26 were from external causes (i.e., accidental overdose, intentional self-harm, accidents, etc.). The most frequent cause of death from external causes was accidental overdose (61.5%). Of these, 26 post-RYGB deaths, 22 were from accidental overdose (n = 16) or intentional self-harm (n = 6) and were included in analyses.
Given the use of EHR data, all deceased patients were accounted for over the study period. Mean age at the time of surgery (n = 22) was 38.4 ± 9.1 years, and the majority were female (77.3%) and White (95.5%). Patient characteristics at the time of surgery are displayed in Table 1 .
For the 22 RYGB patients that died from intentional selfharm or overdose, the mean time from surgery to death via self-harm or accidental overdose was 61.0 ± 34.0 months (range < 1 to 132 months). The mean time from surgery to death via self-harm alone (n = 6) was 40.6 ± 24.7 months. Specific causes of death are listed in Table 2 .
Eight patients (36.4%) were aged 35 or younger at the time of surgery and 15 patients (68.2%) were aged 40 or younger.
Opioid Use and Pain Of the 22 patients, 12 (54.5%) were prescribed an opioid agonist or opioid combination medication at the time of surgery, which is similar to the overall bariatric surgery population at this medical center (Table 3) . At 1-2 years postoperatively, nine continued to have an opioid on their medication list. Notably, 16 patients (72.7%) experienced pain preoperatively (commonly located in the back, knees, and feet).
Psychiatric Medication and Diagnoses
As documented in the EHR, 50.0% (n = 11) had a diagnosis of depressive disorder, 9.1% (n = 2) had non-dependent abuse of drugs, and 9.1% had bipolar disorder/manic depression (n = 2). Regarding medications, 63.6% were prescribed an antidepressant (a serotonin reuptake inhibitor [SSRI], a tricyclic, a serotonin-norepinephrine reuptake inhibitor [SNRI], or a nonspecified antidepressant; Table 3 ). Additionally, 27.2% (n = 6) were prescribed a benzodiazepine (an anxiolytic) or other antianxiety medication, though no patients carried an anxiety disorder diagnosis in the EHR. Diagnoses and medications for patients that died from overdose and self-harm, that died from internal causes, and for the overall RYGB cohort are in Table 3 .
Mental Health History Sixteen patients (72.7%) endorsed a history of previous or current mental health diagnoses or treatment during their behavioral evaluation. Presenting problems were depression (n = 12), stress/anxiety (n = 2), health concerns with behavioral components (n = 2; i.e., headaches, weight), obsessive-compulsive disorder (n = 1), bulimia (n = 1), and posttraumatic stress disorder (n = 1). Five patients (22.7%) reported a history of inpatient psychiatric hospitalizations. Six (27.2%) endorsed a history of suicidal ideation or self-harm behaviors, including episodes of intentional overdose. Three (50.0%) of the six patients that died from intentional self-harm had a history of suicidal ideation or behaviors, and five (83.3%) had a history of depression. Grief and/or traumatic events (i.e., deaths of relatives, some violent) were endorsed by eight patients (36.4%).
A history of binge-eating behaviors was reported by 40.9% (n = 9) of patients and a history of overeating in response to stress was reported by 50.0% (n = 11) patients.
Two patients (9.1%) reported a history of substance use or compulsive behavioral problems.
Beck Depression Inventory-II (BDI-II)
Preoperative BDI-II scores were available for 18 of 22 patients (81.1%) with a mean of 9.9 ± 8.6 (range = 0 to 26), indicating minimal depressive symptoms. The mean score for patients that died from self-harm was 6.5 ± 4.4 (minimal depression), though scores were not available for two patients.
Time to Surgery Mean number of days for patients (N = 22) to undergo surgery from the time of initial consultation was 357 ± 229.4 days.
Expected and Actual Weight Loss
The majority of patients (> 95%) reported reasonable expectations for weight loss outcomes (30-40% of body weight).
Overall, mean total body weight loss at 12 months postsurgery was 34.7 ± 5.8% (range 23.5 to 45.1%).
The body mass index (BMI) of patients that died from selfharm or accidental overdose decreased from 45.7 ± 7.3 to 32.5 ± 8.5 kg/m 2 (− 28.8% BMI change; latest available weight before death, M = 47.6 ± 37.4 postoperative months). Patients who died from self-harm demonstrated a − 36.4% BMI change from surgery to the latest available weight before death.
Social Support and Life Stressors At the time of the presurgical evaluation, 10 patients were married or engaged, four were unmarried or divorced, and five patients' relationship statuses were unknown. Four of the six patients who died from selfharm were married (66.6%). Two patients reported occupational stressors, two reported family issues, and one reported financial issues.
Psychosocial Clearance Nine patients were not initially cleared for surgery (40.9%, Byellow light^; Table 3 ). Reasons for lack of initial clearance were dietary behaviors, lack of weight loss progress or understanding surgery, smoking, and mental health concerns.
Discussion
In the study cohort, 15.1% of weight loss surgery patient deaths were attributable to accidental and intentional overdose (i.e., medication, drugs, alcohol, etc.) and intentional selfharm by firearm. The rate of deaths due to these external causes in this study is moderately higher than previously reported in 2007 (45 of 440, 10.2%) [10] . Reasons for the discrepancy in the rate of deaths from overdose or suicide over the past decade may be the burgeoning opioid crisis, or the differing sample sizes and demographics. Investigation of these rates in larger, more diverse cohorts is warranted. Patients in our study that died intentionally did so after postoperative year 1, which has been previously reported [10] , with most deaths occurring within the first three postoperative years.
Several noteworthy trends were evident. Two thirds of the patients that died intentionally were prescribed an antidepressant at the time of surgery and the vast majority had a diagnosis of depression or bipolar disorder. However, scores on depression assessments indicated minimal depression at the time of evaluation. Future studies should further explore the relationship between a history of depression, regardless of depressive symptomology during the preoperative evaluation period, and the risk for self-harm postoperatively. Morgan and colleagues [3] found a history of hospitalizations for depression preoperatively to be associated with self-harm postoperatively, and several other studies indicated depression among other psychiatric issues to underlie post-surgery completed suicides [2, 22, 23] . While the number of completed suicides in our cohort was small (n = 6), our findings indicate that patients with a history of depression may benefit from preoperative counseling about this risk and from regular postoperative surveillance and screening for mood changes.
More than two thirds of patients who died from accidental overdose or self-harm were aged 40 or younger at the time of surgery. Patients who died from accidental overdose were more than 6 years younger at the time of surgery than patients who died from self-harm, and almost 10 years younger than the greater RYGB cohort at this medical center [8] . Davidson and colleagues [9] did not find a survival benefit for surgery patients under the age of 35 years because of a high rate of externally caused deaths. Collectively, our studies indicate younger age to be a risk factor for premature death from self-harm, overdose, and other external causes in weight loss surgery patients.
The average length of time to surgery was approximately 12 months within the context of a 6-to 12-month preoperative program. Reasons for surgical delay included mental health concerns, maladaptive eating habits, and a lack of readiness for weight loss. Of the patients that died via accidental overdose, half did not initially clear their psychosocial evaluation compared to 31% in the overall cohort. Greater surveillance of patients with extended time to surgery may help to mitigate postoperative risk, but further study and replication in other cohorts are recommended for more definitive conclusions on this potential marker of risk.
In our study, 16 weight loss surgery patients died from accidental overdose. Most patients reported notable pain before surgery and half were prescribed an opioid at the time of surgery. Many of these patients continued to have an opioid listed as an active medication up to 2 years after surgery. Postoperative guidelines recommend the use of opioidsparing strategies unless otherwise contraindicated [24] . Opioids following weight loss surgery may be used to avoid the potential gastrointestinal side effects associated with certain pain medications. We were not, however, able to obtain specific information regarding the substance related to fatal overdoses in our cohort because of limited cause of death information available in the EHR. Given the risk of developing alcohol use disorders following certain weight loss procedures [14] , the high prescribing rates of opioids in this population [25] , and the potential for psychosocial changes postoperatively, greater monitoring of substance use and of medication levels with weight loss is recommended.
Weight change achieved in patients that died intentionally or from accidental overdose was in accordance with weight loss expectations expressed during their preoperative evaluations (30-40% body weight), and all patients achieved weight loss greater than 20% at 1-year postsurgery. We did not detect any notable trends in regard to social support or life stressors, or in reporting of previous compulsive behaviors in patients who died from accidental overdose.
This study has several strengths. To the best of our knowledge, this is the first study to utilize patients' preoperative psychosocial evaluations in combination with other electronic health records to identify clinical characteristics in patients that died from accidental overdose or suicide. However, the small sample size (N = 22) and lack of a control group for comparison limit these findings. Additionally, some patients seeking weight loss surgery may have underreported their mental health histories to avoid denial or delay of surgery. BFaking good,^however, would cause our findings to err on the conservative side. Finally, our cohort did not yet experience deaths in patients with sleeve gastrectomy, but future studies could include sleeve patients when evaluating the risk of externally caused mortality.
Though the potential for death after weight loss surgery from suicide or overdose is of serious concern, the risk is relatively small and most patients do experience significant improvements in health and well-being. Our findings indicate that depression history, younger age, pain, and extended time to surgery may signal the need for changes in clinical care and are targets for future study.
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